• Dermatophytosis – fungal infections involving the body, face, nails, groin, feet, scalp, beard and diaper rash.
• Vaginal candidiasis – fungal infection of the vagina characterized by: moderate to severe itching (pruritus), redness and burning pain during urination, thick white and clumpy discharge (cheese-like) from the vagina, burning vulva discomfort and inflammation of the vulva and vagina.
• Inhibition of the conversion of lanosterol to ergosterol (which is the main constituent of the organism cell wall), by demethylation process in the presence of the enzyme cytochrome p450, thereby leading to increased cellular permeability and eventual death of the fungal cell.

Convenient dosage regimen.

Growth phase independent of fungicidal action

Topical antifungal agent.

Lowest minimum inhibitory concentration and minimum fungicidal concentration of the imidazoles.

Broad spectrum fungicidal action.

Improves patient compliance.

Effective despite the growth phase and reduces the risk of relapse

High safety profile, safe even in pregnancy.

Highly potent and increased clinical confidence in prescription.

Ideal for empirical therapy